Fundación Huésped is a nonprofit foundation in Argentina. It was created in 1989 for the purpose of fighting HIV/AIDS, with a specific focus on creating a social environment that would allow the disease to be overcome.

During the past decade, Fundacion Huesped conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacion Huesped" #1 sponsor was "Fundación Huésped" with 6 trials, followed by "Pedro Cahn" with 4 trials sponsored, "Abbott" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Janssen Vaccines & Prevention B.V." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion Huesped" #1 collaborator was "ViiV Healthcare" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "CanSino Biologics Inc." with 2 trials as a collaborator, "Fundación Huésped" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 23 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion Huesped" are "HIV Infections" (12 trials), "HIV-1 Infection" (3 trials), "HIV Infection" (2 trials), "AIDS" (1 trials) and "Acquired Immune Deficiency Syndrome (AIDS)" (1 trials). Many other conditions were trialed in "Fundacion Huesped" in a lesser frequency.

Most popular intervention types in "Fundacion Huesped" are "Drug" (20 trials), "Biological" (5 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Efavirenz" (3 trials), "Raltegravir" (3 trials), "Stavudine" (3 trials) and "Amprenavir/ritonavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion Huesped" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion Huesped". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Fundacion Huesped, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion Huesped, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 1 trials that are defined as “Not Applicable".